Journals / Turkish Neurosurgery / 2016 / Cilt: 26 - Sayı: 2

Combination of Curcumin with an Anti-Transferrin Receptor Antibody Suppressed the Growth of Malignant Gliomas In vitro

Pages
209–214
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONClUSION: These results provided a potential role of anti-TfR mAb-containing curcumin in the treatment for gliomas.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: Transferrin receptor (TfR) has been used as a target for the molecular cancer therapy due to its higher expression in a variety of tumors.
📊
Key Findings & Data:Anti-TfR antibodies combined with chemotherapeutic drugs has showed great potential as a possible cancer therapeutic strategy.
💡
Conclusion & Impact:CONClUSION: These results provided a potential role of anti-TfR mAb-containing curcumin in the treatment for gliomas.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

AIM: Transferrin receptor (TfR) has been used as a target for the molecular cancer therapy due to its higher expression in a variety of tumors. Anti-TfR antibodies combined with chemotherapeutic drugs has showed great potential as a possible cancer therapeutic strategy. In our study, we investigated the anti-tumor effects of anti-TfR monoclonal antibody (mAb) alone or in combination with curcumin in vitro. MATERIAl and METhODS: We detected the apoptosis, proliferation and cell cycle of glioma cells after treated with anti-TfR mAb and curcumin alone or the combinations by flow cytometer. RESUlTS: Anti-TfR mAb or curcumin could inhibit proliferation of tumor cells. Anti-TfR mAb marked S phase arrest and curcumin induced G2/M arrest in tumor cells. When anti-TfR mAb and curcumin were used simultaneously, a synergistic effect was detected in relation to tumor growth inhibition and the induction of cells necrosis. CONClUSION: These results provided a potential role of anti-TfR mAb-containing curcumin in the treatment for gliomas.

🔖

Cite This Article

WEN, X., CHENG, X., HU, D., LI, W., HA, J., KANG, Z., ZHANG, M., HUANG, Y., WU, S. (2016). Combination of Curcumin with an Anti-Transferrin Receptor Antibody Suppressed the Growth of Malignant Gliomas In vitro. Turkish Neurosurgery, Cilt: 26 - Sayı: 2, 209–214. https://ajindex.com/articles/404650

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Boado RJ, Zhou QH, Lu JZ, Hui EK, Pardridge WM: Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor. Mol Pharm 7:237-244, 2010 2. Lee HJ, Engelhardt B, Lesley J, Bickel U, Pardridge WM: Targeting rat antimouse transferrin receptor monoclonal antibodies through the blood-brain barrier. J Pharmacol Exp Ther 292:1048-1052, 2000 3. Lopez-Lazaro M: Anticancer and carcinogenic properties of Curcumin: Considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res 52:103-127, 2008 4. Ng PP, Helguera G, Daniels TR, Lomas SZ, Rodriguez JA, Schiller G, Bonavida B, Morrison SL, Penichet ML: Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor. Blood 108: 2745-2754, 2006 5. Pardridge WM: Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Bioconjug Chem 19:1327- 1338, 2008 6. Peng JL, Wu S, Zhao XP, Wang M, Li WH, Shen X, Liu J, Lei P, Zhu HF, Shen GX: Downregulation of transferrin receptor surface expression by intracellular antibody. Biochem Biophys Res Commun 354:864-871, 2007 7. Qing Y, Shuo W, Zhihua W, Huifen Z, Ping L, Lijiang L, Xiaorong Z, Liming C, Daiwen X, Yu H, Wei X, Min F, Zuohua F, Guanxin S: The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor. Cancer Immunol Immunother 55:1111-1121, 2006 8. Quiles S, Raisch KP, Sanford LL, Bonner JA, Safavy A: Synthesis and preliminary biological evaluation of high-drug-load paclitaxelantibody conjugates for tumor-targeted chemotherapy. J Med Chem 53:586-594, 2010 9. Ravindran J, Prasad S, Aggarwal BB: Curcumin and cancer cells: How many ways can curry kill tumor cells selectively? AAPS J 11: 495-510, 2009 10. Senft C, Polacin M, Priester M, Seifert V, Kogel D, Weissenberger J: The nontoxic natural compound Curcumin exerts antiproliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer 10:491, 2010 11. Shen X, Zhu HF, He FR, Xing W, Li L, Liu J, Yang J, Pan XF, Lei P, Wang ZH, Shen GX: An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human non-hematopoietic tumor cells. Int Immunopharmacol 8:1813-1820, 2008 12. Shi N, Boado RJ, Pardridge WM: Antisense imaging of gene exp